Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > Global Kidney Cancer Diagnosis Market Research Report 2025

Global Kidney Cancer Diagnosis Market Research Report 2025

Global Kidney Cancer Diagnosis Market Research Report 2025

Industry: Medical Devices & Consumables

Published: 2025-01-13

Pages: 78 Pages

Report ld: 3492915

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for Kidney Cancer Diagnosis was valued at US$ 535 million in the year 2024 and is projected to reach a revised size of US$ 750 million by 2031, growing at a CAGR of 5.0% during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Kidney Cancer Diagnosis Market Size(US$)

M= millions and B=billions

QYRLogo
Report Scope
This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Diagnosis.

The Kidney Cancer Diagnosis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney Cancer Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney Cancer Diagnosis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

  • Report Metric

  • Details

  • Report Title

  • Global Kidney Cancer Diagnosis Market Research Report 2025

  • Forecasted Market Size in 2031

  • US$ 750 million

  • CAGR(2025-2031)

  • 5%

  • Market Size Available for Years

  • 2025-2031

  • Global Kidney Cancer Diagnosis Companies Covered

  • Myriad Genetics Inc.

    NeoGenomics Laboratories

    Thermo Fisher Scientific Inc.

    Sysmex Corporation

    Rosetta Genomics

    Illumina Inc.

    Abbott Laboratories

    Roche Holding AG

  • Global Kidney Cancer Diagnosis Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Kidney Cancer Diagnosis Market, Segment by Type

  • Immunohistochemical Test

    Complete Blood Count Test

    Urine Test

    Blood Chemistry Test

  • Global Kidney Cancer Diagnosis Market, Segment by Application

  • Hospital

    Surgery Center

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Kidney Cancer Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of Kidney Cancer Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 

Table of Contents

1 Kidney Cancer Diagnosis Market Overview
    1.1 Product Definition
    1.2 Kidney Cancer Diagnosis by Type
        1.2.1 Global Kidney Cancer Diagnosis Market Value Comparison by Type (2024 VS 2031)
        1.2.2 Immunohistochemical Test
        1.2.3 Complete Blood Count Test
        1.2.4 Urine Test
        1.2.5 Blood Chemistry Test
    1.3 Kidney Cancer Diagnosis by Application
        1.3.1 Global Kidney Cancer Diagnosis Market Value by Application (2024 VS 2031)
        1.3.2 Hospital
        1.3.3 Surgery Center
    1.4 Global Kidney Cancer Diagnosis Market Size Estimates and Forecasts
        1.4.1 Global Kidney Cancer Diagnosis Revenue 2020-2031
        1.4.2 Global Kidney Cancer Diagnosis Sales 2020-2031
        1.4.3 Global Kidney Cancer Diagnosis Market Average Price (2020-2031)
    1.5 Assumptions and Limitations
2 Kidney Cancer Diagnosis Market Competition by Manufacturers
    2.1 Global Kidney Cancer Diagnosis Sales Market Share by Manufacturers (2020-2025)
    2.2 Global Kidney Cancer Diagnosis Revenue Market Share by Manufacturers (2020-2025)
    2.3 Global Kidney Cancer Diagnosis Average Price by Manufacturers (2020-2025)
    2.4 Global Key Players of Kidney Cancer Diagnosis, Industry Ranking, 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Kidney Cancer Diagnosis, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Kidney Cancer Diagnosis, Product Type & Application
    2.7 Global Key Manufacturers of Kidney Cancer Diagnosis, Date of Enter into This Industry
    2.8 Global Kidney Cancer Diagnosis Market Competitive Situation and Trends
        2.8.1 Global Kidney Cancer Diagnosis Market Concentration Rate
        2.8.2 The Global 5 and 10 Largest Kidney Cancer Diagnosis Players Market Share by Revenue
        2.8.3 Global Kidney Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Kidney Cancer Diagnosis Market Scenario by Region
    3.1 Global Kidney Cancer Diagnosis Market Size by Region: 2020 Versus 2024 Versus 2031
    3.2 Global Kidney Cancer Diagnosis Sales by Region: 2020-2031
        3.2.1 Global Kidney Cancer Diagnosis Sales by Region: 2020-2025
        3.2.2 Global Kidney Cancer Diagnosis Sales by Region: 2026-2031
    3.3 Global Kidney Cancer Diagnosis Revenue by Region: 2020-2031
        3.3.1 Global Kidney Cancer Diagnosis Revenue by Region: 2020-2025
        3.3.2 Global Kidney Cancer Diagnosis Revenue by Region: 2026-2031
    3.4 North America Kidney Cancer Diagnosis Market Facts & Figures by Country
        3.4.1 North America Kidney Cancer Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
        3.4.2 North America Kidney Cancer Diagnosis Sales by Country (2020-2031)
        3.4.3 North America Kidney Cancer Diagnosis Revenue by Country (2020-2031)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Kidney Cancer Diagnosis Market Facts & Figures by Country
        3.5.1 Europe Kidney Cancer Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
        3.5.2 Europe Kidney Cancer Diagnosis Sales by Country (2020-2031)
        3.5.3 Europe Kidney Cancer Diagnosis Revenue by Country (2020-2031)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Kidney Cancer Diagnosis Market Facts & Figures by Region
        3.6.1 Asia Pacific Kidney Cancer Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
        3.6.2 Asia Pacific Kidney Cancer Diagnosis Sales by Region (2020-2031)
        3.6.3 Asia Pacific Kidney Cancer Diagnosis Revenue by Region (2020-2031)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Kidney Cancer Diagnosis Market Facts & Figures by Country
        3.7.1 Latin America Kidney Cancer Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
        3.7.2 Latin America Kidney Cancer Diagnosis Sales by Country (2020-2031)
        3.7.3 Latin America Kidney Cancer Diagnosis Revenue by Country (2020-2031)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Kidney Cancer Diagnosis Market Facts & Figures by Country
        3.8.1 Middle East and Africa Kidney Cancer Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
        3.8.2 Middle East and Africa Kidney Cancer Diagnosis Sales by Country (2020-2031)
        3.8.3 Middle East and Africa Kidney Cancer Diagnosis Revenue by Country (2020-2031)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE
4 Segment by Type
    4.1 Global Kidney Cancer Diagnosis Sales by Type (2020-2031)
        4.1.1 Global Kidney Cancer Diagnosis Sales by Type (2020-2025)
        4.1.2 Global Kidney Cancer Diagnosis Sales by Type (2026-2031)
        4.1.3 Global Kidney Cancer Diagnosis Sales Market Share by Type (2020-2031)
    4.2 Global Kidney Cancer Diagnosis Revenue by Type (2020-2031)
        4.2.1 Global Kidney Cancer Diagnosis Revenue by Type (2020-2025)
        4.2.2 Global Kidney Cancer Diagnosis Revenue by Type (2026-2031)
        4.2.3 Global Kidney Cancer Diagnosis Revenue Market Share by Type (2020-2031)
    4.3 Global Kidney Cancer Diagnosis Price by Type (2020-2031)
5 Segment by Application
    5.1 Global Kidney Cancer Diagnosis Sales by Application (2020-2031)
        5.1.1 Global Kidney Cancer Diagnosis Sales by Application (2020-2025)
        5.1.2 Global Kidney Cancer Diagnosis Sales by Application (2026-2031)
        5.1.3 Global Kidney Cancer Diagnosis Sales Market Share by Application (2020-2031)
    5.2 Global Kidney Cancer Diagnosis Revenue by Application (2020-2031)
        5.2.1 Global Kidney Cancer Diagnosis Revenue by Application (2020-2025)
        5.2.2 Global Kidney Cancer Diagnosis Revenue by Application (2026-2031)
        5.2.3 Global Kidney Cancer Diagnosis Revenue Market Share by Application (2020-2031)
    5.3 Global Kidney Cancer Diagnosis Price by Application (2020-2031)
6 Key Companies Profiled
    6.1 Myriad Genetics Inc.
        6.1.1 Myriad Genetics Inc. Company Information
        6.1.2 Myriad Genetics Inc. Description and Business Overview
        6.1.3 Myriad Genetics Inc. Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2020-2025)
        6.1.4 Myriad Genetics Inc. Kidney Cancer Diagnosis Product Portfolio
        6.1.5 Myriad Genetics Inc. Recent Developments/Updates
    6.2 NeoGenomics Laboratories
        6.2.1 NeoGenomics Laboratories Company Information
        6.2.2 NeoGenomics Laboratories Description and Business Overview
        6.2.3 NeoGenomics Laboratories Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2020-2025)
        6.2.4 NeoGenomics Laboratories Kidney Cancer Diagnosis Product Portfolio
        6.2.5 NeoGenomics Laboratories Recent Developments/Updates
    6.3 Thermo Fisher Scientific Inc.
        6.3.1 Thermo Fisher Scientific Inc. Company Information
        6.3.2 Thermo Fisher Scientific Inc. Description and Business Overview
        6.3.3 Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2020-2025)
        6.3.4 Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Product Portfolio
        6.3.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
    6.4 Sysmex Corporation
        6.4.1 Sysmex Corporation Company Information
        6.4.2 Sysmex Corporation Description and Business Overview
        6.4.3 Sysmex Corporation Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2020-2025)
        6.4.4 Sysmex Corporation Kidney Cancer Diagnosis Product Portfolio
        6.4.5 Sysmex Corporation Recent Developments/Updates
    6.5 Rosetta Genomics
        6.5.1 Rosetta Genomics Company Information
        6.5.2 Rosetta Genomics Description and Business Overview
        6.5.3 Rosetta Genomics Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2020-2025)
        6.5.4 Rosetta Genomics Kidney Cancer Diagnosis Product Portfolio
        6.5.5 Rosetta Genomics Recent Developments/Updates
    6.6 Illumina Inc.
        6.6.1 Illumina Inc. Company Information
        6.6.2 Illumina Inc. Description and Business Overview
        6.6.3 Illumina Inc. Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2020-2025)
        6.6.4 Illumina Inc. Kidney Cancer Diagnosis Product Portfolio
        6.6.5 Illumina Inc. Recent Developments/Updates
    6.7 Abbott Laboratories
        6.7.1 Abbott Laboratories Company Information
        6.7.2 Abbott Laboratories Description and Business Overview
        6.7.3 Abbott Laboratories Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2020-2025)
        6.7.4 Abbott Laboratories Kidney Cancer Diagnosis Product Portfolio
        6.7.5 Abbott Laboratories Recent Developments/Updates
    6.8 Roche Holding AG
        6.8.1 Roche Holding AG Company Information
        6.8.2 Roche Holding AG Description and Business Overview
        6.8.3 Roche Holding AG Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2020-2025)
        6.8.4 Roche Holding AG Kidney Cancer Diagnosis Product Portfolio
        6.8.5 Roche Holding AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
    7.1 Kidney Cancer Diagnosis Industry Chain Analysis
    7.2 Kidney Cancer Diagnosis Raw Material Supply Analysis
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Kidney Cancer Diagnosis Production Mode & Process Analysis
    7.4 Kidney Cancer Diagnosis Sales and Marketing
        7.4.1 Kidney Cancer Diagnosis Sales Channels
        7.4.2 Kidney Cancer Diagnosis Distributors
    7.5 Kidney Cancer Diagnosis Customer Analysis
8 Kidney Cancer Diagnosis Market Dynamics
    8.1 Kidney Cancer Diagnosis Industry Trends
    8.2 Kidney Cancer Diagnosis Market Drivers
    8.3 Kidney Cancer Diagnosis Market Challenges
    8.4 Kidney Cancer Diagnosis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Kidney Cancer Diagnosis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Kidney Cancer Diagnosis Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Kidney Cancer Diagnosis Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Kidney Cancer Diagnosis Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Kidney Cancer Diagnosis Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Kidney Cancer Diagnosis Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Kidney Cancer Diagnosis Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Kidney Cancer Diagnosis, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Kidney Cancer Diagnosis, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Kidney Cancer Diagnosis, Product Type & Application
 Table 12. Global Key Manufacturers of Kidney Cancer Diagnosis, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Kidney Cancer Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Diagnosis as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Kidney Cancer Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Kidney Cancer Diagnosis Sales by Region (2020-2025) & (K Units)
 Table 18. Global Kidney Cancer Diagnosis Sales Market Share by Region (2020-2025)
 Table 19. Global Kidney Cancer Diagnosis Sales by Region (2026-2031) & (K Units)
 Table 20. Global Kidney Cancer Diagnosis Sales Market Share by Region (2026-2031)
 Table 21. Global Kidney Cancer Diagnosis Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Kidney Cancer Diagnosis Revenue Market Share by Region (2020-2025)
 Table 23. Global Kidney Cancer Diagnosis Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Kidney Cancer Diagnosis Revenue Market Share by Region (2026-2031)
 Table 25. North America Kidney Cancer Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Kidney Cancer Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 27. North America Kidney Cancer Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 28. North America Kidney Cancer Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Kidney Cancer Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Kidney Cancer Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Kidney Cancer Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Kidney Cancer Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Kidney Cancer Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Kidney Cancer Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Kidney Cancer Diagnosis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Kidney Cancer Diagnosis Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Kidney Cancer Diagnosis Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Kidney Cancer Diagnosis Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Kidney Cancer Diagnosis Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Kidney Cancer Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Kidney Cancer Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Kidney Cancer Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Kidney Cancer Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Kidney Cancer Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Kidney Cancer Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Kidney Cancer Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Kidney Cancer Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Kidney Cancer Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Kidney Cancer Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Kidney Cancer Diagnosis Sales (K Units) by Type (2020-2025)
 Table 51. Global Kidney Cancer Diagnosis Sales (K Units) by Type (2026-2031)
 Table 52. Global Kidney Cancer Diagnosis Sales Market Share by Type (2020-2025)
 Table 53. Global Kidney Cancer Diagnosis Sales Market Share by Type (2026-2031)
 Table 54. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Kidney Cancer Diagnosis Revenue Market Share by Type (2020-2025)
 Table 57. Global Kidney Cancer Diagnosis Revenue Market Share by Type (2026-2031)
 Table 58. Global Kidney Cancer Diagnosis Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Kidney Cancer Diagnosis Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Kidney Cancer Diagnosis Sales (K Units) by Application (2020-2025)
 Table 61. Global Kidney Cancer Diagnosis Sales (K Units) by Application (2026-2031)
 Table 62. Global Kidney Cancer Diagnosis Sales Market Share by Application (2020-2025)
 Table 63. Global Kidney Cancer Diagnosis Sales Market Share by Application (2026-2031)
 Table 64. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Kidney Cancer Diagnosis Revenue Market Share by Application (2020-2025)
 Table 67. Global Kidney Cancer Diagnosis Revenue Market Share by Application (2026-2031)
 Table 68. Global Kidney Cancer Diagnosis Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Kidney Cancer Diagnosis Price (US$/Unit) by Application (2026-2031)
 Table 70. Myriad Genetics Inc. Company Information
 Table 71. Myriad Genetics Inc. Description and Business Overview
 Table 72. Myriad Genetics Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Myriad Genetics Inc. Kidney Cancer Diagnosis Product
 Table 74. Myriad Genetics Inc. Recent Developments/Updates
 Table 75. NeoGenomics Laboratories Company Information
 Table 76. NeoGenomics Laboratories Description and Business Overview
 Table 77. NeoGenomics Laboratories Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. NeoGenomics Laboratories Kidney Cancer Diagnosis Product
 Table 79. NeoGenomics Laboratories Recent Developments/Updates
 Table 80. Thermo Fisher Scientific Inc. Company Information
 Table 81. Thermo Fisher Scientific Inc. Description and Business Overview
 Table 82. Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Product
 Table 84. Thermo Fisher Scientific Inc. Recent Developments/Updates
 Table 85. Sysmex Corporation Company Information
 Table 86. Sysmex Corporation Description and Business Overview
 Table 87. Sysmex Corporation Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sysmex Corporation Kidney Cancer Diagnosis Product
 Table 89. Sysmex Corporation Recent Developments/Updates
 Table 90. Rosetta Genomics Company Information
 Table 91. Rosetta Genomics Description and Business Overview
 Table 92. Rosetta Genomics Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Rosetta Genomics Kidney Cancer Diagnosis Product
 Table 94. Rosetta Genomics Recent Developments/Updates
 Table 95. Illumina Inc. Company Information
 Table 96. Illumina Inc. Description and Business Overview
 Table 97. Illumina Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Illumina Inc. Kidney Cancer Diagnosis Product
 Table 99. Illumina Inc. Recent Developments/Updates
 Table 100. Abbott Laboratories Company Information
 Table 101. Abbott Laboratories Description and Business Overview
 Table 102. Abbott Laboratories Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Abbott Laboratories Kidney Cancer Diagnosis Product
 Table 104. Abbott Laboratories Recent Developments/Updates
 Table 105. Roche Holding AG Company Information
 Table 106. Roche Holding AG Description and Business Overview
 Table 107. Roche Holding AG Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Roche Holding AG Kidney Cancer Diagnosis Product
 Table 109. Roche Holding AG Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Kidney Cancer Diagnosis Distributors List
 Table 113. Kidney Cancer Diagnosis Customers List
 Table 114. Kidney Cancer Diagnosis Market Trends
 Table 115. Kidney Cancer Diagnosis Market Drivers
 Table 116. Kidney Cancer Diagnosis Market Challenges
 Table 117. Kidney Cancer Diagnosis Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Kidney Cancer Diagnosis
 Figure 2. Global Kidney Cancer Diagnosis Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Kidney Cancer Diagnosis Market Share by Type: 2024 & 2031
 Figure 4. Immunohistochemical Test Product Picture
 Figure 5. Complete Blood Count Test Product Picture
 Figure 6. Urine Test Product Picture
 Figure 7. Blood Chemistry Test Product Picture
 Figure 8. Global Kidney Cancer Diagnosis Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Kidney Cancer Diagnosis Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Surgery Center
 Figure 12. Global Kidney Cancer Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Kidney Cancer Diagnosis Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Kidney Cancer Diagnosis Sales (2020-2031) & (K Units)
 Figure 15. Global Kidney Cancer Diagnosis Average Price (US$/Unit) & (2020-2031)
 Figure 16. Kidney Cancer Diagnosis Report Years Considered
 Figure 17. Kidney Cancer Diagnosis Sales Share by Manufacturers in 2024
 Figure 18. Global Kidney Cancer Diagnosis Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Kidney Cancer Diagnosis Players: Market Share by Revenue in Kidney Cancer Diagnosis in 2024
 Figure 20. Kidney Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Kidney Cancer Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Kidney Cancer Diagnosis Sales Market Share by Country (2020-2031)
 Figure 23. North America Kidney Cancer Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 24. United States Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Kidney Cancer Diagnosis Sales Market Share by Country (2020-2031)
 Figure 27. Europe Kidney Cancer Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Kidney Cancer Diagnosis Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Kidney Cancer Diagnosis Revenue Market Share by Region (2020-2031)
 Figure 35. China Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Kidney Cancer Diagnosis Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Kidney Cancer Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Kidney Cancer Diagnosis Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Kidney Cancer Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Kidney Cancer Diagnosis by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Kidney Cancer Diagnosis by Type (2020-2031)
 Figure 56. Global Kidney Cancer Diagnosis Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Kidney Cancer Diagnosis by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Kidney Cancer Diagnosis by Application (2020-2031)
 Figure 59. Global Kidney Cancer Diagnosis Price (US$/Unit) by Application (2020-2031)
 Figure 60. Kidney Cancer Diagnosis Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed

Description 

The global market for Kidney Cancer Diagnosis was valued at US$ 535 million in the year 2024 and is projected to reach a revised size of US$ 750 million by 2031, growing at a CAGR of 5.0% during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Diagnosis.

The Kidney Cancer Diagnosis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney Cancer Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney Cancer Diagnosis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Kidney Cancer Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of Kidney Cancer Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
den_biaoTiZhungShi

Related Reports

Global Kidney Cancer Diagnosis Market Research Report 2025

Industry: Medical Devices & Consumables

Published: 2025-01-13

Pages: 78 Pages

Report ld: 3492915

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now